This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Saniona A/s. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Jørgen Buus Lassen: Innovator in Pharmaceutical Compositions
Introduction
Jørgen Buus Lassen is a notable inventor based in Bagsværd, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the area of combination therapy. His innovative work focuses on enhancing therapeutic efficacy while minimizing side effects.
Latest Patents
Jørgen holds a patent for "Pharmaceutical compositions for combination therapy." This invention relates to the use of pharmaceutical compositions that combine Tesofensine and Metoprolol. The goal of this combination is to prevent the cardiovascular side effects associated with Tesofensine, while maintaining its effectiveness in reducing food intake and promoting body weight loss. He has 1 patent to his name.
Career Highlights
Jørgen is currently associated with Saniona A/S, a company dedicated to developing innovative treatments for various medical conditions. His work at Saniona has allowed him to explore new avenues in pharmaceutical research and development.
Collaborations
Throughout his career, Jørgen has collaborated with talented individuals such as Henrik Björk Hansen and Morten Grunnet. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Jørgen Buus Lassen is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact the treatment of various health conditions. His innovative approach to combination therapy exemplifies the importance of research and collaboration in the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile